Can denosumab be a substitute, competitor, or complement to bisphosphonates?

MLA

Hwoe Gyeong Ok, et al. “Can Denosumab Be a Substitute, Competitor, or Complement to Bisphosphonates?” The Korean Journal of Pain, vol. 30, no. 2, Mar. 2017, pp. 86–92. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6aa9a762bfe5c49266bce03d9591d20e&authtype=sso&custid=ns315887.

APA

Hwoe Gyeong Ok, Christof Birkenmaier, Su Young Kim, & Kyung-Hoon Kim. (2017). Can denosumab be a substitute, competitor, or complement to bisphosphonates? The Korean Journal of Pain, 30(2), 86–92.

Chicago

Hwoe Gyeong Ok, Christof Birkenmaier, Su Young Kim, and Kyung-Hoon Kim. 2017. “Can Denosumab Be a Substitute, Competitor, or Complement to Bisphosphonates?” The Korean Journal of Pain 30 (2): 86–92. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6aa9a762bfe5c49266bce03d9591d20e&authtype=sso&custid=ns315887.